<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Regulation of fibrinolysis by plasminogen activator inhibitor-1 (PAI-1), α2-antiplasmin, and thrombin-activatable fibrinolysis inhibitor (TAFI)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Regulation of fibrinolysis by plasminogen activator inhibitor-1 (PAI-1), α2-antiplasmin, and thrombin-activatable fibrinolysis inhibitor (TAFI)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Regulation of fibrinolysis by plasminogen activator inhibitor-1 (PAI-1), α2-antiplasmin, and thrombin-activatable fibrinolysis inhibitor (TAFI)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">PAI-1 inhibits plasmin formation by inhibiting t-PA. α<sub>2</sub>-antiplasmin inhibits the activity of plasmin, thereby inhibiting fibrinolysis. TAFI circulates in plasma as a zymogen. It is activated by thrombin when thrombin is bound on to its endothelial cofactor TM, and therefore represents a link between blood coagulation and fibrinolysis. During fibrinolysis, plasmin cleaves intact fibrin at lysine residues, initially yielding large, insoluble fibrin fragments with lysine residues at their carboxyl termini. Plasminogen binds avidly to C-terminal lysine residues within the partially degraded fibrin clot and assumes a conformation that is susceptible to activation by t-PA, thereby promoting plasmin formation, continued fibrinolysis ("rapid fibrinolysis"), and generation of smaller, soluble fibrin fragments that are dispersed by flowing blood. Activated TAFI (TAFI<sub>a</sub>) is a carboxypeptidase that removes lysine residues from the C-termini of partially degraded fibrin fragments. By removing C-terminal lysine residues from large fibrin fragments in the partially degraded clot, TAFI inhibits recruitment of plasminogen to the clot, thereby slowing fibrinolysis ("slow fibrinolysis").</div><div class="graphic_footnotes">PAI-1: plasminogen activator inhibitor-1; t-PA: tissue-type plasminogen activator; TAFI: thrombin-activatable fibrinolysis inhibitor; TAFI<sub>a</sub>: activated form of TAFI; TM: thrombomodulin.</div><div class="graphic_reference">Diagram supplied by William P Fay, MD.</div><div id="graphicVersion">Graphic 81428 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
